Dr. Paul Peter Tak
@paulpetertak
Followers
2K
Following
11K
Media
118
Statuses
2K
Physician-scientist. Professor. Former Chief Immunology Officer of GSK. CEO of Candel Therapeutics ($CADL). Views expressed here are my own. Likes≠endorsement.
Needham, MA
Joined August 2013
I might add: empathy and compassion.
In clinical practice, empathy refers to understanding and reflecting on a patient’s emotional state while maintaining constructive discussions about care. Physician empathy has been linked to better clinical outcomes, improved prescribing practices, stronger therapeutic
1
0
11
Congratulations to our super CRO on receiving this prestigious award!
Congratulations to Candel’s Chief Regulatory Officer Susan Stewart, on receiving the regulatory profession's highest honor - the RAPS Founder’s Award! https://t.co/Ra3rSbP7mu $CADL #RAPSAwards #RegulatoryAffairs
3
0
19
Congratulations on having been awarded the Nobel Prize for this amazing work! We live in the continuous era of immunology - in autoimmunity, immuno-oncology, neuro-immunology, infectious diseases, and beyond.
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
2
0
12
The R&D approach needs a rethink - no-one disagrees, but only a few have challenged themselves - even with some of their portfolio… Puts a lot of misplaced faith in a model they all know is wrong https://t.co/9YMQk1XlL2
1
1
8
Don’t underestimate the power of human collective intelligence. A key feature of transformative teams. (Woolley AW et al. Evidence for a collective intelligence factor in the performance of human groups. Science 2010;330:686-688)
A 2024 study found that ants best humans at tests of collective intelligence. Learn more on #WorldAnimalDay: https://t.co/MyBnb7vROX
@NewsfromScience
4
1
15
We’ll be at #SITC2025! Presenting posters on our enLIGHTEN platform and CAN-2409 in NSCLC, plus our CEO @paulpetertak will speak on our phase 3 prostate cancer data. See the curtain raiser: https://t.co/9Mb8TkDyMH
#Immunotherapy #ProstateCancer #NSCLC
0
2
14
Candel’s Chief Regulatory Officer, moderating the panel "Conversations that Matter: Interactions with Health Authorities".
linkedin.com
I am so excited to be moderating panels with Jethro Ekuta at #RAPSConvergence! I hope you will join me and a group of drug and device global Health Authority officials for our session, "Conversations...
0
0
9
Our prostate cancer data from the phase 3 CAN-2409 trial will be presented in an oral presentation at the Future Directions in Urology Symposium by Dr. John E. Sylvester from Atlantic Urology Clinics. https://t.co/xglePNaEpq
#ProstateCancer #Urology $CADL
0
3
21
We’re presenting our phase 3 CAN-2409 localized prostate cancer trial at #ASTRO2025, with a subanalysis focused on type of radiation therapy used in the trial. https://t.co/k1c7Tq7UlJ
#ProstateCancer #ClinicalData #RadiationOncology
2
2
19
Looking forward to giving the Keynote Lecture tomorrow at ”Global Medical Education at the Bicentennial" as part of the 200th anniversary celebrations of the Faculty of Medicine of the University of Lisbon.
medicina.ulisboa.pt
As part of the 200th anniversary celebrations of the Faculty of Medicine of the University of Lisbon, the international event Global Medical Education at the Bicentennial will take place on September...
1
0
17
Harnessing the power of viruses to fight brain cancer: The exceptional story of Kyle Donohue who was treated with CAN-3110 because of recurrent glioblastoma.
thetech.com
The drug CAN-3110 helped Kyle Donohue beat the odds. Now, it’s in clinical trials.
4
2
24
.@paulpetertak @CandelTx discusses the company's viral immunotherapy for brain cancer, how it works, and what clinical studies have shown to date. @GlobalGenes #RARECast
https://t.co/DsMOSFXLZf
2
3
15
Attending #ASTRO25? Dr. Gejerman will present our phase 3 prostate cancer study. The data represents potential progress for ~65k men diagnosed annually with intermediate-to-high-risk localized prostate cancer who undergo radiotherapy with curative intent. https://t.co/OpRlzLEUNk
1
3
20
And in business
Understanding probability is essential in data science. In 4 minutes, I'll demolish your confusion. Let's go!
1
0
15
Our CEO @PaulPeterTak and VP of IR & BD Ted Jenkins are attending BioCentury Grand Rounds. We’ll discuss our enLIGHTEN™ Discovery Platform and how it systematically identifies tumor microenvironment characteristics that correlate with clinical outcomes. https://t.co/qxdiAD5Dbu
0
2
17
I really appreciate your response @JacobPlieth. Debating helps in the context of truth-seeking, and X is a good platform to do so. Engaging in constructive debate is great and I want to thank you for this. Moving forward, I will be happy to answer any questions and provide
"The comments about the SPA are also completely wrong and misleading, as Candel has strictly adhered to the agreement with the FDA and the SPA is intact" From $CADL 14 Nov 2024 SEC filing (8/8)
5
2
24